Rheumatology International
| 期刊全称 | Rheumatology International | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 期刊缩写 | RHEUMATOL INT | |||||||||||||||||||||||||||||||||||||||
| 涉及主题 | 医学内科学生物心理学病理精神科放射科免疫学痹症科外科遗传学疾病化学类风湿性关节炎生物化学内分泌学关节炎胃肠病学数学物理疗法皮肤病科 | |||||||||||||||||||||||||||||||||||||||
| 期刊介绍 | RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology. RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. | |||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | print: 0172-8172 on-line: 1437-160 | |||||||||||||||||||||||||||||||||||||||
| 历年影响因子 |
| |||||||||||||||||||||||||||||||||||||||
| 历年发表/被引量 |
| |||||||||||||||||||||||||||||||||||||||
| h-Index | 66 | |||||||||||||||||||||||||||||||||||||||
| 自引率 | 6.20% | |||||||||||||||||||||||||||||||||||||||
| 涉及的研究领域 | 医学-风湿病学 | |||||||||||||||||||||||||||||||||||||||
| 2026年新锐分区 |
| |||||||||||||||||||||||||||||||||||||||
| 中科院2025年分区 ? |
| |||||||||||||||||||||||||||||||||||||||
| WOS期刊分区 | JCR学科分类
JCI学科分类
| |||||||||||||||||||||||||||||||||||||||
| 期刊主页 | https://www.springer.com/296https://www.springer.com/journal/296 | |||||||||||||||||||||||||||||||||||||||
| 投稿网址 | https://www.editorialmanager.com/rhei/ | |||||||||||||||||||||||||||||||||||||||
| 出版商 | Springer Berlin Heidelberg | |||||||||||||||||||||||||||||||||||||||
| 出版国家（地区） | GERMANY | |||||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||||
| 出版周期 | Tri-annual | |||||||||||||||||||||||||||||||||||||||
| 每年出版文章数 | 280 | |||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 30.03% | |||||||||||||||||||||||||||||||||||||||
| 原创研究文献占比 (排除综述) | 67.69% | |||||||||||||||||||||||||||||||||||||||
| SCI收录类型 | Science Citation Index Expanded (SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||||||||
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0172-8172%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||
| 平均审稿周期 | 平均16.月 | |||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 约75% | |||||||||||||||||||||||||||||||||||||||
| 相关链接 | 您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。 |